Abstract: A pharmaceutical agent for the prevention or treatment of any of the following conditions in mammals: atherosclerosis, thrombosis, unwanted high levels of free radicals, unwanted long fibrin clot lysis times, unwanted fibrin clot characteristics, unwanted high levels of free fatty acids and obesity, is provided. The agent comprises a short chain fatty acid, or a pharmaceutically acceptable salt, derivative or precursor thereof, in a pharmaceutically acceptable protective coating which is resistant to digestion and solution in the stomach and small intestine of a mammal, but digestible or soluble in the colon of a mammal. Preferably the agent comprises calcium acetate in a shellac coating.

Abstract: A modular concept for a gun which uses a breech conversion kit allows the firing of cased and caseless ammunition with the same gun. The cannon has 2 breech mechanism (10) which includes a first sliding breech-block (19) which engages the rear end (15) of a cartridge case in the firing position. Said first sliding breech-block (19) is interchanged for a second sliding breech-block (21) when firing caseless ammunition. Said second breech-block is in contact with a scaling member (23) which is mounted pivotally on an axis (27) which is located on the upper face of breech ring (11).